OBJECTIVES: The clinical translation of tissue-engineered vascular grafts has been demonstrated in children. The remodeling of biodegradable, cell-seeded scaffolds to functional neovessels has been partially attributed to matrix metalloproteinases. Noninvasive assessment of matrix metalloproteinase activity can indicate graft remodeling and elucidate the progression of neovessel formation. Therefore, matrix metalloproteinase activity was evaluated in grafts implanted in lambs using in vivo and ex vivo hybrid imaging. Graft growth and remodeling was quantified using in vivo x-ray computed tomography angiography. METHODS: Cell-seeded and unseeded scaffolds were implanted in 5 lambs as inferior vena cava interposition grafts. At 2 and 6 months after implantation, in vivo angiography was used to assess graft morphology. In vivo and ex vivo single photon emission tomography/computed tomography imaging was performed with a radiolabeled compound targeting matrix metalloproteinase activity at 6 months. The neotissue was examined at 6 months using qualitative histologic and immunohistochemical staining and quantitative biochemical analysis. RESULTS: The seeded grafts demonstrated significant luminal and longitudinal growth from 2 to 6 months. In vivo imaging revealed subjectively greater matrix metalloproteinase activity in grafts versus native tissue. Ex vivo imaging confirmed a quantitative increase in matrix metalloproteinase activity and demonstrated greater activity in unseeded versus seeded grafts. The glycosaminoglycan content was increased in seeded grafts versus unseeded grafts, without significant differences in collagen content. CONCLUSIONS: Matrix metalloproteinase activity remained elevated in tissue-engineered grafts 6 months after implantation and could indicate remodeling. Optimization of in vivo imaging to noninvasively evaluate matrix metalloproteinase activity could assist in the serial assessment of vascular graft remodeling.
OBJECTIVES: The clinical translation of tissue-engineered vascular grafts has been demonstrated in children. The remodeling of biodegradable, cell-seeded scaffolds to functional neovessels has been partially attributed to matrix metalloproteinases. Noninvasive assessment of matrix metalloproteinase activity can indicate graft remodeling and elucidate the progression of neovessel formation. Therefore, matrix metalloproteinase activity was evaluated in grafts implanted in lambs using in vivo and ex vivo hybrid imaging. Graft growth and remodeling was quantified using in vivo x-ray computed tomography angiography. METHODS: Cell-seeded and unseeded scaffolds were implanted in 5 lambs as inferior vena cava interposition grafts. At 2 and 6 months after implantation, in vivo angiography was used to assess graft morphology. In vivo and ex vivo single photon emission tomography/computed tomography imaging was performed with a radiolabeled compound targeting matrix metalloproteinase activity at 6 months. The neotissue was examined at 6 months using qualitative histologic and immunohistochemical staining and quantitative biochemical analysis. RESULTS: The seeded grafts demonstrated significant luminal and longitudinal growth from 2 to 6 months. In vivo imaging revealed subjectively greater matrix metalloproteinase activity in grafts versus native tissue. Ex vivo imaging confirmed a quantitative increase in matrix metalloproteinase activity and demonstrated greater activity in unseeded versus seeded grafts. The glycosaminoglycan content was increased in seeded grafts versus unseeded grafts, without significant differences in collagen content. CONCLUSIONS: Matrix metalloproteinase activity remained elevated in tissue-engineered grafts 6 months after implantation and could indicate remodeling. Optimization of in vivo imaging to noninvasively evaluate matrix metalloproteinase activity could assist in the serial assessment of vascular graft remodeling.
Authors: Ian Cummings; Sarah George; Jens Kelm; Doerthe Schmidt; Maximilian Y Emmert; Benedikt Weber; Gregor Zünd; Simon P Hoerstrup Journal: Eur J Cardiothorac Surg Date: 2012-01 Impact factor: 4.191
Authors: Brooks Udelsman; Narutoshi Hibino; Gustavo A Villalona; Edward McGillicuddy; Alejandro Nieponice; Yuki Sakamoto; Shojiro Matsuda; David A Vorp; Toshiharu Shinoka; Christopher K Breuer Journal: Tissue Eng Part C Methods Date: 2011-05-06 Impact factor: 3.056
Authors: Narutoshi Hibino; Gustavo Villalona; Nicholas Pietris; Daniel R Duncan; Adam Schoffner; Jason D Roh; Tai Yi; Lawrence W Dobrucki; Dane Mejias; Rajendra Sawh-Martinez; Jamie K Harrington; Albert Sinusas; Diane S Krause; Themis Kyriakides; W Mark Saltzman; Jordan S Pober; Toshiharu Shin'oka; Christopher K Breuer Journal: FASEB J Date: 2011-05-12 Impact factor: 5.191
Authors: Haili Su; Francis G Spinale; Lawrence W Dobrucki; James Song; Jing Hua; Sarah Sweterlitsch; Donald P Dione; Patti Cavaliere; Conroy Chow; Brian N Bourke; Xiao-Yu Hu; Michael Azure; Padmaja Yalamanchili; Richard Liu; Edward H Cheesman; Simon Robinson; D Scott Edwards; Albert J Sinusas Journal: Circulation Date: 2005-11-07 Impact factor: 29.690
Authors: Narutoshi Hibino; Tai Yi; Daniel R Duncan; Animesh Rathore; Ethan Dean; Yuji Naito; Alan Dardik; Themis Kyriakides; Joseph Madri; Jordan S Pober; Toshiharu Shinoka; Christopher K Breuer Journal: FASEB J Date: 2011-08-24 Impact factor: 5.191
Authors: Yuji Naito; Misty Williams-Fritze; Daniel R Duncan; Spencer N Church; Narutoshi Hibino; Joseph A Madri; Jay D Humphrey; Toshiharu Shinoka; Christopher K Breuer Journal: Cells Tissues Organs Date: 2011-10-12 Impact factor: 2.481
Authors: Jason D Roh; Gregory N Nelson; Matthew P Brennan; Tamar L Mirensky; Tai Yi; Tyrone F Hazlett; George Tellides; Albert J Sinusas; Jordan S Pober; W M Saltzman; Themis R Kyriakides; Christopher K Breuer Journal: Biomaterials Date: 2007-12-27 Impact factor: 12.479
Authors: Matthew P Brennan; Alan Dardik; Narutoshi Hibino; Jason D Roh; Gregory N Nelson; Xenophon Papademitris; Toshiharu Shinoka; Christopher K Breuer Journal: Ann Surg Date: 2008-09 Impact factor: 12.969
Authors: Mitchel R Stacy; Cameron A Best; Mark W Maxfield; Maolin Qiu; Yuji Naito; Hirotsugu Kurobe; Nathan Mahler; Kevin A Rocco; Albert J Sinusas; Toshiharu Shinoka; Smita Sampath; Christopher K Breuer Journal: Tissue Eng Part C Methods Date: 2018-07-31 Impact factor: 3.056
Authors: Saurav Ranjan Mohapatra; Elena Rama; Christoph Melcher; Tobias Call; Miriam Aischa Al Enezy-Ulbrich; Andrij Pich; Christian Apel; Fabian Kiessling; Stefan Jockenhoevel Journal: Tissue Eng Regen Med Date: 2022-10-06 Impact factor: 4.451
Authors: Kevin M Blum; Jacob C Zbinden; Abhay B Ramachandra; Stephanie E Lindsey; Jason M Szafron; Aaron J Trask; Jay D Humphrey; Alison L Marsden; Toshiharu Shinoka; Christopher K Breuer; James W Reinhardt; Megan Heitkemper; Cameron A Best; Gabriel J M Mirhaidari; Yu-Chun Chang; Anudari Ulziibayar; John Kelly; Kejal V Shah; Joseph D Drews; Jason Zakko; Shinka Miyamoto; Yuichi Matsuzaki; Ryuma Iwaki; Hira Ahmad; Robbie Daulton; Drew Musgrave; Matthew G Wiet; Eric Heuer; Emily Lawson; Erica Schwarz; Michael R McDermott; Rajesh Krishnamurthy; Ramkumar Krishnamurthy; Kan Hor; Aimee K Armstrong; Brian A Boe; Darren P Berman Journal: Commun Med (Lond) Date: 2022-01-10
Authors: Mark W Maxfield; Mitchel R Stacy; Hirotsugu Kurobe; Shuhei Tara; Tai Yi; Muriel A Cleary; Zhen W Zhuang; Manuel I Rodriguez-Davalos; Sukru H Emre; Yasuko Iwakiri; Toshiharu Shinoka; Christopher K Breuer Journal: Regen Med Date: 2017-12-07 Impact factor: 3.806
Authors: Ramak Khosravi; Abhay B Ramachandra; Jason M Szafron; Daniele E Schiavazzi; Christopher K Breuer; Jay D Humphrey Journal: Integr Biol (Camb) Date: 2020-04-14 Impact factor: 2.192
Authors: John Joseph; Vito Domenico Bruno; Nadiah Sulaiman; Alexander Ward; Thomas W Johnson; Helna Mary Baby; Praveen Kerala Varma; Rajesh Jose; Shantikumar V Nair; Deepthy Menon; Sarah Jane George; Raimondo Ascione Journal: J Nanobiotechnology Date: 2022-02-08 Impact factor: 9.429